1. A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study. Issue 9 (September 2022) Authors: Kleppe, Andreas; Skrede, Ole-Johan; De Raedt, Sepp; Hveem, Tarjei S; Askautrud, Hanne A; Jacobsen, Jørn E; Church, David N; Nesbakken, Arild; Shepherd, Neil A; Novelli, Marco; Kerr, Rachel; Liestøl, Knut; Kerr, David J; Danielsen, Håvard E Journal: Lancet oncology Issue: Volume 23:Issue 9(2022) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer predisposition syndromes: lessons for truly precision medicine. Issue 2 (30th November 2016) Authors: Glaire, Mark A; Brown, Matthew; Church, David N; Tomlinson, Ian Editors: Bonthron, David T; Foulkes, William D Journal: Journal of pathology Issue: Volume 241:Issue 2(2017) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Issue 10221 (1st February 2020) Authors: Skrede, Ole-Johan; De Raedt, Sepp; Kleppe, Andreas; Hveem, Tarjei S; Liestøl, Knut; Maddison, John; Askautrud, Hanne A; Pradhan, Manohar; Nesheim, John Arne; Albregtsen, Fritz; Farstad, Inger Nina; Domingo, Enric; Church, David N; Nesbakken, Arild; Shepherd, Neil A; Tomlinson, Ian; Kerr, Rachel; ... Journal: Lancet Issue: Volume 395:Issue 10221(2019) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape. Issue 3 (1st April 2022) Authors: Glaire, Mark A; Ryan, Neil AJ; Ijsselsteijn, Marieke E; Kedzierska, Katarzyna; Obolenski, Sofia; Ali, Reem; Crosbie, Emma J; Bosse, Tjalling; de Miranda, Noel FCC; Church, David N Journal: Journal of pathology Issue: Volume 257:Issue 3(2022) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer. (13th May 2020) Authors: Roseweir, Antonia K; Park, James H; Hoorn, Sanne ten; Powell, Arfon GMT; Aherne, Susan; Roxburgh, Campbell SD; McMillan, Donald C; Horgan, Paul G; Ryan, Elizabeth; Sheahan, Kieran; Vermeulen, Louis; Paul, James; Harkin, Andrea; Graham, Janet; Sansom, Owen; Church, David N; Tomlinson, Ian; Saunder... Journal: Journal of pathology Issue: Volume 6:Number 4(2020) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Interpretation of somatic POLE mutations in endometrial carcinoma. Issue 3 (29th January 2020) Authors: León‐Castillo, Alicia; Britton, Heidi; McConechy, Melissa K; McAlpine, Jessica N; Nout, Remi; Kommoss, Stefan; Brucker, Sara Y; Carlson, Joseph W; Epstein, Elisabeth; Rau, Tilman T; Bosse, Tjalling; Church, David N; Gilks, C Blake Journal: Journal of pathology Issue: Volume 250:Issue 3(2020) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. (September 2018) Authors: Domingo, Enric; Camps, Carme; Kaisaki, Pamela J; Parsons, Marie J; Mouradov, Dmitri; Pentony, Melissa M; Makino, Seiko; Palmieri, Michelle; Ward, Robyn L; Hawkins, Nicholas J; Gibbs, Peter; Askautrud, Hanne; Oukrif, Dahmane; Wang, Haitao; Wood, Joe; Tomlinson, Evie; Bark, Yasmine; Kaur, Kulvinder... Journal: Lancet gastroenterology and hepatology Issue: Volume 3:Number 9(2018) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer. (14th January 2019) Authors: Gray, Victoria; Briggs, Sarah; Palles, Claire; Jaeger, Emma; Iveson, Timothy; Kerr, Rachel; Saunders, Mark P; Paul, James; Harkin, Andrea; McQueen, John; Summers, Matthew G; Johnstone, Elaine; Wang, Haitao; Gatcombe, Laura; Maughan, Timothy S; Kaplan, Richard; Escott-Price, Valentina; Al-Tassan, ... Journal: Journal of the National Cancer Institute Issue: Volume 111:Number 8(2019) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PI3K–AKT–mTOR inhibitors for the systemic treatment of endometrial cancer. (September 2012) Authors: Church, David N; Koppensteiner, Romana; Yap, Timothy A; Fink, Daniel; Dedes, Konstantin J Journal: Expert review of obstetrics & gynecology Issue: Volume 7:Number 5(2012) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PI3K–AKT–mTOR inhibitors for the systemic treatment of endometrial cancer. (September 2012) Authors: Church, David N; Koppensteiner, Romana; Yap, Timothy A; Fink, Daniel; Dedes, Konstantin J Journal: Expert review of obstetrics & gynecology Issue: Volume 7:Number 5(2012) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗